FDA Brief

Warning letters Food

FDA warning letter to

The Camel Milk Co. LLC dba Camel Culture

High riskIssued Sep 22, 2021Posted Oct 19, 2021Office of Human and Animal Foods Operations – Division West 4

FDA warned The Camel Milk Co. over camel milk products marketed as drugs to treat COVID-19, autism, and other conditions.

What happened

FDA reviewed the company’s website in July and August 2021 and also reviewed its Facebook and Instagram pages, which direct consumers to the website to buy Camel Milk and Dry Camel Milk Powder. FDA found claims and testimonials that the products treat or prevent COVID-19, autism, infections, diarrhea, and reflux. FDA determined the products are unapproved new drugs and are misbranded.

What FDA found

  1. The website and social media claims make the camel milk products drugs because they are intended to cure, mitigate, treat, or prevent disease.

    FD&C Act section 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]
  2. The products are new drugs not generally recognized as safe and effective for the claimed uses and are sold without FDA approval.

    FD&C Act sections 201(p), 301(d), and 505(a) [21 U.S.C. 321(p), 331(d), 355(a)]
  3. The products are misbranded because they lack adequate directions for use for diseases that a layperson cannot safely self-treat.

    FD&C Act section 502(f)(1) [21 U.S.C. 352(f)(1)]
  4. Introducing or delivering these misbranded drugs into interstate commerce violates the law.

    FD&C Act section 301(a) [21 U.S.C. 331(a)]

What FDA wants

FDA asks the company to stop selling any unapproved products for COVID-19 and to notify FDA in writing within 15 working days of the steps taken to address the violations and prevent recurrence.

Who should pay attention

  • food and beverage brands making health claims online
  • online sellers using social media testimonials
  • companies marketing products for COVID-19 or autism

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk